| Application no. and date | 16710378.7 (espacenet) (Federated) (European Patent Register), 20160226 | | Patent/reg. no. and date | DK/EP 3262168, 20190821 | | Publication date | 20180103 | | Priority no. and date | US 201562126213 P, 20150227, US 201662298869 P, 20160223 | | EP pub. no. and date |
EP 3262168 20180103 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | P69452DK01 | | Inventor | BURAKOV, Darya, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
GOREN, Michael, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
CHEN, Gang, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C12N 15/09 (2006.01) | | Title | VÆRTSCELLEPROTEINMODIFIKATION | | Int. application no. | US2016019915 | | Int. publication no. | WO2016138467 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
